Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease
NCT ID: NCT00671684
Last Updated: 2008-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
50 participants
INTERVENTIONAL
2007-10-31
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease
NCT05461924
Electrophysiological Activity of the Anorectum in Children Suspected of Hirschsprung Disease
NCT02342457
MICROPRUNG : Intestinal Microbiota Analysis in Patients With or Without Hirschsprung's Associated EnteroColitis
NCT02857205
Full Thickness vs. Rectal Suction Biopsy in the Diagnosis of Hirschsprungs Disease
NCT05307419
Effects of Butyrate Enemas on Postoperative Intestinal Mobility Disorders in Hirschsprung's Disease
NCT03660176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic Mucosal Resection (EMR)
EMR is a common procedure in gastroenterology. The technique involves placing a band around a piece of mucosa in the GI tract. The band and the tissue are then removed using a cautery snare. The technique can be used to obtain tissue for diagnostic purposes or to remove lesions for therapeutic purposes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* contraindication to endoscopy
* untreated or unmanageable coaguloapathy
* thrombocytopenia (\<50)
* inability to provide informed consent.
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Massachusetts General Hosptial
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Field F Willingham, MD, MPH
Role: STUDY_DIRECTOR
MGH
Garrett C Zella, MD
Role: STUDY_DIRECTOR
MGH
Mari Mino-Kenudson, MD
Role: STUDY_DIRECTOR
MGH
Braden Kuo, MD
Role: PRINCIPAL_INVESTIGATOR
MGH
William R Brugge, MD, FASGE
Role: STUDY_DIRECTOR
MGH
Leonel Rodriguez, MD
Role: PRINCIPAL_INVESTIGATOR
MGH
Clarissa Foy, NP
Role: STUDY_DIRECTOR
MGH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Massachusetts General Hosptial
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007P001577
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.